Discount Plans (27)
Long Term Care (28)
Medical Savings Accounts
United States (130)
Alabama, Alaska, Arizona, Arkansas, California....
TAHIRPUR, India (AP) — At first, Ashok Yadav ignored the patches of pink skin on his arm. But when pale sores erupted on his body and he lost sensation in his fingertips, a doctor issued the devastating diagnosis: Yadav had leprosy.
German health regulators have granted Northwest Biotherapeutics Inc special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small U.S. biotechnology company has not yet completed its late-stage trial of the immunotherapy. The special "hospital exemption" in Germany would allow Northwest to sell DCVax-L for five years, and to seek renewed approval afterward, Northwest Biotherapeutics Chief Executive Officer Linda Powers said in an interview. The company has not yet requested or received formal marketing approval for its product. The exemption allows Northwest to sell DCVax-L through hospitals and their outpatient clinics to patients with all severities of cancer that begin in the brain, even though it is only being tested in patients newly diagnosed with the most severe form of the disease, called Glioblastoma multiforme (GBM).